Quincy Hofsink

Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19

Sabine Haggenburg, Quincy Hofsink, Birgit I. Lissenberg‐Witte et al. · JAMA Oncology · 2022 · 85 citations · Full text

Medicine, Immunology, Oncology +17

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

Sabine Haggenburg, Birgit I. Lissenberg‐Witte, Rob van Binnendijk et al. · Blood Advances · 2022 · 63 citations · Full text

Medicine, Hematology, Immunology +15

Post-hepatectomy liver regeneration in the context of bile acid  homeostasis and the gut-liver signaling axis

Quincy Hofsink, Pim B. Olthof, Mark J. de Keijzer et al. · Journal of Clinical and Translational Research · 2018 · 32 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: A Randomized, Controlled Trial

Sammy Huygens, Quincy Hofsink, Inger S. Nijhof et al. · The Journal of Infectious Diseases · 2022 · 27 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12

The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma – a substudy of the SORAMIC trial

Tim A. Labeur, Quincy Hofsink, R. Bart Takkenberg et al. · Acta Oncologica · 2020 · 17 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17